Logo | Name | Σ | ||
---|---|---|---|---|
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3849 | 2669 | 204 | |
Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: Bank | 12636 | 9605 | 1604 | |
Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing … Sectors: Health | 964 | 790 | 143 | |
Direction Générale des Entreprises [Automatic translation follows] The DGE designs and implements policies in favor of competitiveness and business growth. The Directorate General for Enterprises serves the Minister of Economy and Finance. Our action is at the heart of the Government's projects in favor of the country's economic transformation and strategic autonomy. In the service of business competitiveness, it carries out industrial policy, defines digital regulatory measures, as well as policies to support the local economy. It supports businesses in the digital and ecological transformation of the economy, and works in favor of regulatory simplification and an ambitious innovation policy. Its missions include both … Sectors: National and local authorities | 1520 | 1129 | 227 | |
Air Liquide Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902. Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. … | 1486 | 1121 | 333 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3559 | 2655 | 836 | |
Haute Autorité de Santé [Automatic translation follows] Official page of the High Authority for Health (HAS), an independent public authority with a scientific character The HAS is an independent public authority whose aim is to contribute to the regulation of the health system through quality. Its missions in the fields of the evaluation of health products, professional practices, the organization of care and public health, aim to ensure that all patients and users have sustainable and equitable access to care that is as effective, safe and efficient as possible. | 485 | 361 | 111 | |
Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: Startup accelerator & VC | 727 | 387 | 261 | |
Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 652 | 392 | 395 | |
BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: Biotechnology French Cluster Public business cluster | 419 | 169 | 318 | |
France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 880 | 513 | 530 | |
Ministère de la Santé [Automatic translation follows] Official account of the Ministry of Health and Access to Care. The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity | 1320 | 974 | 201 | |
EU Green Capital The official #EUGreenCapital and #EUGreenLeaf Awards. Our aim is to improve Europe's urban environment. The European Green Capital and European Green Leaf awards are a European Commission initiative to recognise a city's commitment to a better urban environment. Cities with populations over 100,000 inhabitants are eligible to apply for the European Green Capital Award while the European Green Leaf is open to cities of between 20,000 and 100,000 inhabitants. Winners demonstrate well-established records of high environmental standards and a commitment to setting ambitious goals for future environmental progress, underpinned by the practical application of sustainable development. The schemes have a … Sectors: European Union | 10599 | 7638 | 1329 | |
Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: National and local authorities | 5398 | 3297 | 2389 | |
Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 1008 | 716 | 265 | |
Gouvernement The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players ! | 2315 | 1780 | 660 | |
Ministère des Solidarités [Automatic translation follows] The Ministry of Labor, Health, Solidarity and Families is responsible for designing and implementing government policies, particularly in terms of solidarity, autonomy and inclusiveness of people with disabilities. | 596 | 433 | 84 | |
Centre Interministériel de Services Informatiques relatifs aux Ressources Humaines (CISIRH) [Automatic translation follows] A nationally competent service, the CISIRH is working on the digital modernization of the State's HR function The Interministerial Center for Human Resources IT Services (CISIRH) is a nationally competent service (SCN) created by decree of February 9, 2015. The CISIRH is placed under a triple supervision: General Directorate of Administration and Civil Service (DGAFP), General Directorate of Public Finances (DGFIP) and Budget Directorate (DB). It contributes to the program to modernize the State's HR-payroll chain coordinated by the DINSIC. The CISIRH has approximately 125 agents spread across 6 departments and offices that bring together very varied … | 2905 | 2076 | 803 | |
GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1120 | 735 | 402 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1796 | 1591 | 123 | |
Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1417 | 1102 | 137 |